Mice that lack PEMT have reduced plasma levels of PC and cholesterol in high density lipoproteins (HDL). We have investigated the mechanism responsible for this reduction with experiments designed to distinguish between a decreased formation of HDL particles by hepatocytes or an increased hepatic uptake of HDL lipids. Therefore, we analyzed lipid efflux to apoA1 and HDL lipid uptake using primary cultured hepatocytes isolated from P e m t 
Phosphatidylethanolamine Nmethyltransferase (PEMT) is a liverspecific enzyme that converts p h o s p h a t i d y l e t h a n o l a m i n e t o phosphatidylcholine (PC).
Mice that lack PEMT have reduced plasma levels of PC and cholesterol in high density lipoproteins (HDL). We have investigated the mechanism responsible for this reduction with experiments designed to distinguish between a decreased formation of HDL particles by hepatocytes or an increased hepatic uptake of HDL lipids. Therefore, we analyzed lipid efflux to apoA1 and HDL lipid uptake using primary cultured hepatocytes isolated from P e m t Phosphatidylcholine (PC) 1 plays a crucial role in the maintenance of membrane integrity and is involved in intracellular signal transduction. PC is also the predominant phospholipid found in plasma lipoproteins, bile and lung surfactant (1) . All mammalian cells can synthesize PC from choline via the Kennedy (CDP-choline) pathway (2) . The rate-limiting enzyme for this synthetic route is CTP:phosphocholine cytidylyltransferase (3). In the liver, an alternative pathway contributes to the biosynthesis of PC. This pathway involves three successive methylations of phosphatidylethanolamine (PE) catalyzed by PE N-methyltransferase (PEMT) and represents a third of hepatic PC production (4, 5) . The liverspecific expression of this enzyme has suggested several roles for PEMTderived PC in hepatic metabolism, including its involvement in lipoprotein metabolism (5) (6) (7) (8) and bile secretion (9, 10) . In 1997, a mouse lacking PEMT was generated to gain further insight into the function of this enzyme. When fed a chow diet, Pemt -/-mice appear normal and the production of PC from the Kennedy pathway is increased by approximately 50% to compensate for the absence of the PEMT activity (11) . Indeed, hepatic levels of PC do not change significantly between the Pemt +/+ and Pemt -/-mice. However, when Pemt -/-mice are fed a cholinedeficient diet to attenuate the CDPcholine pathway, severe liver damage occurred within three days (12) . The liver failure can be reversed if choline is fed to the mice prior to the third day of the choline-deficient diet (13) . I n t e r e s t i n g l y , n e i t h e r d i e t a r y dimethylethanolamine ( 1 4 ) n o r propanolamine (15) can substitute for dietary choline when fed to Pemt -/-mice, indicating a striking specificity for PC in liver function. It is believed that the PEMT pathway survived throughout evolution to provide PC in situations where choline intake is insufficient, such as pregnancy/lactation or starvation (12) .
More recently, the role of PEMT in very low density lipoprotein metabolism was examined. PEMT deficiency in male mice challenged with a high fat/high cholesterol diet resulted in a 50% decrease in apoB100, PC and triacylglycerol (TG) secretion from the liver (9) . These observations are in agreement with earlier work in which levels of secreted apoB100 and lipids (PC and TG) (17) , reduction in PC degradation, and/or regulation of lipid flux in and out of hepatocytes to maintain PC levels constant and ensure optimal liver functions. In this respect, a significant reduction of cholesterol and PC in plasma HDL is observed in both genders of Pemt -/-mice fed a HF/HC diet. Surprisingly, these lower HDL levels were also detected in female Pemt -/-mice fed a chow diet (18). This decrease in plasma HDL lipids is intriguing, particularly since a role for PEMT in HDL metabolism has not been previously addressed.
In the last decade, many studies have focused on HDL formation, maturation and delivery of its associated lipids to the liver.
This reverse cholesterol transport (19) (20) (21) ) is believed to be atheroprotective since HDL mediates the transport of excess cholesterol from peripheral tissues back to the liver for conversion into bile acids and/or for excretion into bile (22) (23) (24) . The generation of HDL particles from poorly-lipidated apoA-1 involves the efflux of cellular lipids and relies on the activity of the ATP-binding cassette transporter A1 (ABCA1). In addition, partially lipidated "nascent" HDL can acquire unesterified cholesterol in an ABCA1-independent manner via other ABC transporters, such as ABCG1 or ABCG4, or via a passive diffusion process (25) (26) (27) Because hepatocytes secrete apoA-1, express ABCA1 on their cell surface and can generate HDL by both ABCA1-dependent and -independent pathways (28, 29) , we considered the possibility that ABCA1-mediated efflux of PC and cholesterol from PEMT-deficient hepatocytes might be decreased as a mechanism for maintaining PC homeostasis in the liver.
It is also now well established that lipids associated with HDL can be delivered to steroidogenic tissues (adrenals, ovary or testes) and to the liver via the scavenger receptor class B, type I (SR-BI) (30) . This HDL receptor is mainly expressed on the cell surface of hepatocytes and steroidogenic cells and is involved in the selective uptake of lipids from plasma lipoproteins, without concomitant degradation of the whole lipoprotein particle (31) . Thus, cholesteryl esters and other lipids are segregated from apoA-1, which is recycled back to the plasma compartment while lipids are thought to be targeted to the canalicular membrane for biliary secretion. Although SR-BI has also been described as a promoter of cholesterol efflux (32) , the absence of a cholesterol efflux defect from SR-BIdeficient mouse macrophages to HDL suggests SR-BI has anti-atherosclerotic effects for reasons other than cholesterol efflux (33) . Currently, SR-BI is believed to play a crucial role in the final step of reverse cholesterol transport, i.e the selective uptake and sorting of plasma HDL lipids (32, 34, 35 The PC standard was purchased from Avanti Polar Lipids (Alabaster, AL). Cholesterol, cholesteryl oleate ester standards, 6-amino-n-hexanoic acid and dodecyl maltoside were obtained from Sigma (Oakville, ON). The BCA protein kit including the bovine serum albumin standard was obtained from Pierce (Rockford, IL). Rabbit polyclonal antimouse SR-BI (NB 400-101), goat polyclonal anti-SR-BI (NB 400-131), rabbit polyclonal anti-PDZK1 (NB 400-149) and rabbit polyclonal anti-human ABCA1 antibodies were obtained from Novus Biologicals (Littleton, CO). Rabbit polyclonal anti-human apoA-1 antibodies were from Biodesigns (Kennebunk, ME). Rabbit polyclonal anti-rat protein disulfide isomerase antibody was from StressGen, Victoria, BC. Goat anti-rabbit IgG secondary antibody conjugated to horseradish peroxidase was from Pierce (Rockford, I L ) a n d t h e e n h a n c e d chemiluminescence detection system was from Amersham Biosciences (Buckinghamshire, UK). Cholesterol and choline-containing phospholipids were analyzed by fast protein liquid chromatography using the Infinity Cholesterol reagent from ThermoDMA (Calgary, AB) and Phospholipids B kit from Wako Diagnostics (Richmond, VA), respectively. All other chemicals and reagents were from standard commercial sources.
Reagents for qPCR analysis of mRNA levels were purchased from Invitrogen (Burlington, ONT). The molecular weight markers for the Blue Native PAGE were from A m e r s h a m B i o s c i e n c e s (Buckinghamshire, UK and Pemt -/-mice were fasted overnight after which they were injected via the tail vein with 200 µl of [ electrophoresis on polyacrylamide gels (containing 0.1 % SDS) (6% gel for ABCA1 analysis, 12.5% gel for SR-BI and 10% for PDZK1) and the resolved proteins were transferred onto a nitrocellulose membrane. ABCA1 (1:250 dilution), SR-BI (1:5,000 dilution) and PDZK1 (1:3,000 dilution) were detected using specific primary antibodies. For each immunoblot, protein disfulfide isomerase (1:2,000 dilution) was used as a loading control. The apoA-1 immunoblot (1:10,000 dilution) was performed with fresh plasma and the membrane was stained with Coomassie Blue to confirm equal loading into each lane of the gel. Densitometric analysis of the blots was performed using Quantity One software. ), detergent-insoluble material was removed and 50 µg of samples were combined to Blue Native-PAGE sample buffer 5X (50 mM bis-Tris-HCl, pH 7, 50% glycerol, 25 mg/mL Coomassie Blue G250 and 375 mM 6-amino-nhexanoic acid). The electrophoresis was performed in non-reducing conditions (SDS-free buffers and equipment) on a 4-20% gradient polyacrylamide gel and the immunoblot analysis of SR-BI oligomeric forms was performed as described above.
S-metabolic Labeling of SR-BI in
For all statistical analyses, Pemt +/+ mice were compared with Pemt -/-animals from the same gender using the Student's t test.
RESULTS
Plasma HDL Lipids are Decreased by PEMT Deficiency-A s i g n i f i c a n t reduction of plasma lipid levels was previously observed in chow-fed Pemt -/-mice compared to Pemt +/+ mice (18). To investigate the mechanism responsible for this decrease, we first analyzed the lipoprotein profiles of plasma from mice of the two genotypes by fast protein liquid chromatograpy. The mice had been fasted overnight prior to the analysis. Both cholesterol (Fig. 1A) and choline-containing phospholipids (Fig.  1B) were lower in plasma of mice lacking PEMT compared to mice with PEMT.
ABCA1 Mediated Lipid Efflux is not Decreased by the Absence of PEMT-
We next evaluated the role of PEMTderived PC in HDL formation. Primary cultured hepatocytes, obtained from Pemt and Pemt -/-hepatocytes into the medium was determined after a 16 h incubation ± apoA-1. The amount of cholesterol in the culture medium was analyzed by gas-liquid chromatography (Fig. 2A) and Pemt -/-mice were homogenized and hepatic levels of ABCA1 protein were evaluated by immunoblot analysis (Fig. 2C) . Densitometric analysis of immunoblots for ABCA1 protein from 7 mice of each genotype revealed no significant change in ABCA1 levels in the livers from mice lacking PEMT compared to P e m t , mice is not due to reduced expression or activity of hepatic ABCA1. Since apoA-1 is the major apolipoprotein of HDL, we determined whether or not apoA-1 levels were altered by the absence of PEMT. Plasma (2 µl) was collected from Pemt +/+ and Pemt -/-mice and analyzed for apoA-1 by immunoblot analysis. The immunoblot membrane was also stained with Coomassie Blue to show total proteins as a loading control. Even though the amounts of HDL PC and cholesterol were significantly lower in mice lacking PEMT (Fig. 1) (Fig. 4) . The uptake of both radiolabeled lipids was linear with respect to time of incubation (up to 240 min) and protein concentration (up to 250 µg/ml of radiolabeled HDL) (data not shown). and Pemt -/-mice were collected after the lipid uptake assay and the level of cellular SR-BI protein was evaluated by immunoblot analysis (Fig. 6A) . Densitometry quantification of immunoblots for SR-BI from 10 mice of each genotype revealed a significantly higher (1.5-fold, p < 0.05)) level of SR-B1 in hepatocytes lacking PEMT than in Pemt +/+ hepatocytes (Fig. 6B) . Similarly, analysis of liver homogenates from Pemt
and Pemt -/-mice revealed a corresponding 1.6-fold (p < 0.001) increase in SR BI expression in the PEMT-deficient livers ( Fig. 6C and 6D ).
Increased SR-BI Protein in Pemt -/-

Hepatocytes is Not the Result of Upregulated SR-BI mRNA Expression-
Our data suggest that the absence of hepatic PEMT activity results in enhanced lipid uptake, most likely via the pathway mediated by SR-BI. Therefore, we analyzed SR-BI protein synthesis and degradation in primary cultures from both genotypes using [ 35 S]-metabolic labeling. Following a pulse period of 2 h to allow the radiolabeling of newly synthesized proteins, the degradation of SR-BI protein was analyzed over a time period of 0 to 8 h of chase. Figure 7A shows hepatocytes. In addition to these metabolic studies, hepatic SR-BI mRNA levels were analyzed using real-time PCR (Fig.  7C) . When compared to their wildtype counterparts, the Pemt -/-mice did not show any significant difference in SR-BI mRNA transcripts detected in liver homogenates.
Blue Native Polyacrylamide Gel Electrophoresis of Hepatic SR-BI-
To characterize the various oligomeric forms of hepatic SR-BI, we used Blue Native PAGE analysis. This method is based on separation by charge and is believed to achieve higher resolution of protein complexes than other nondenaturating techniques (41) . Liver homogenates were electrophoresed on a 4-20% gradient gel and SR-BI complexes were visualized by immunoblotting. Figure 8 is representative of the data obtained from n ≥ 6 mice of each genotype, showing two samples from Pemt +/+ mice on the left and three samples from Pemt -/-mice on the right. A monomeric form of SR-BI is detected at ~82 kDa in every lane, although the exact molecular size can only be grossly approximated when using the Blue Native PAGE. Dimers of SR-BI can be visualized at ~160 kDa. Moreover, the Blue Native PAGE analysis reveals the presence of higher order complexes, likely oligomers of SR-BI associated with itself or with other proteins, which is in agreement with previous reports of the multimerization of SR-BI in different steroidogenic and non-steroidogenic cells (42, 43) . It is noteworthy that the size of these complexes does not differ significantly between genotypes, even though the total SR-BI present is greater in liver homogenates from Pemt -/-mice. The upregulation of SR-BI protein results in significantly higher levels of SR-BI monomers and, to a lesser extent, of SR-BI dimers (Fig. 8) . This indicates that increases in SR-BI protein expression correspond indeed to a greater lipid uptake potential (Fig. 4) but does not necessarily translate into more oligomeric complexes, although they are also more abundant as well in the absence of PEMT. (Fig. 9) . As confirmed by the densitometry analysis, the absence of the PEMT pathway induces a 1.5-fold increase in PDZK1 levels (* p > 0.005).
DISCUSSION
In this study, we have addressed the mechanism by which PEMT deficiency in mice reduces the levels of cholesterol and PC in plasma (18), a decrease that occurs primarily in HDL (Fig.1) .
Two hypotheses were considered based on our current understanding of the mechanisms that can alter the levels of lipids in plasma HDL:
(i) decreased hepatic HDL formation as a consequence of a lack of PC biosynthesis or (ii) a possible increase in lipid uptake by the liver to replenish hepatic PC stores.
ABCA-1 Mediated Lipid Efflux is Not Decreased in the Absence of PEMT Activity.
HDL removes excess cholesterol from peripheral tissues for delivery to steroidogenic organs and to the liver.
However, hepatocytes, in concert with enterocytes, synthesize and secrete most of the apoA1 found in the plasma compartment, and express ABCA1, thus making the liver a major contributor to HDL formation (29, 45) . The assembly of HDL particles from lipid-poor apoA1 requires the efflux of both phospholipids and cholesterol and relies on the action of ABCA1 (46) . In humans, the absence of ABCA1 activity results in Tangier disease and near absence of HDL particles with an increased risk of cardiovascular disease (25) . To determine if PEMT-derived PC is involved in the lipidation of apoA1, we investigated HDL formation by Pemt ABCA1-mediated efflux of cholesterol and PC is unaffected by the absence of PEMT. Moreover, the hepatic expression of ABCA1 is similar in mice of both P e m t genotypes. This is consistent with ABCA1 expression being regulated by cellular cholesterol levels (25) , which are unchanged in the livers of Pemt -/-compared to P e m t +/+ mice (18). Reduction of hepatic ABCA1 activity is associated with decreased plasma apoA-I levels (47), which we did not find (Fig. 3) , further supporting the conclusion that absence of PEMT activity does not affect hepatic ABCA1 expression or activity.
Recently, other members of the ABC transporter family have been implicated in mobilization of cholesterol and/or phospholipids from cells to HDL (46, 48) . ABCG1 mediates the efflux of cholesterol to partially lipidated "nascent" HDL, but studies have suggested that its contribution to hepatic lipoprotein production or clearance is minimal (49, 50) . ABCA7 has the highest homology known to ABCA1 (~54%) and promotes selective cellular phospholipid efflux to apoA-1 (49) (50) (51) (52) . It is unlikely that ABCG1 or ABCA7 are responsible for the decreased levels of plasma HDL lipids, as murine hepatocytes have very low levels of ABCG1 mRNA (49, 50) and ABCA7 protein is virtually absent from murine liver (45) . Thus, the decreased plasma HDL lipid levels cannot be explained by a reduced efflux of hepatic lipids in Pemt -/-mice.
Lipid Uptake from HDL is Increased in the Absence of PEMT Activity. The final step of reverse cholesterol transport involves the uptake of HDL lipids in the liver via SR-BI, a cell surface receptor that mediates selective lipid uptake. In fact, approximately 60 to 80% of plasma cholesterol is cleared from the rodent circulation by the liver (53) . After hepatic uptake, cholesterol can be metabolized and excreted into bile by cellular sorting mechanisms that are still under investigation (54) (55) (56) .
The results from the lipid uptake experiments strongly suggest that the lower levels of plasma cholesterol and PC can be, in part, attributed to a greater amount of hepatic SR-BI in Pemt -/-mice when compared to Pemt +/+ mice. This conclusion is also supported by our finding of no significant difference in plasma apoA-I levels in mice lacking PEMT activity. Selective lipid uptake, first described by Glass et al. (23) , involves the recycling of apoA1 to the plasma compartment. Accordingly, over-expression of SR-BI is accompanied by a significant decrease in HDL cholesterol but plasma apoA1 concentration remains unchanged (22) . Thus, our findings are consistent with an involvement of SR-BI in regulating plasma lipid levels when hepatic PC biosynthesis is challenged. The present study shows that expression of SR-BI in hepatocytes is up-regulated by the absence of PEMT, and this is accompanied by a significant increase in the ability of P e m t -/-hepatocytes to accept HDL cholesterol and PC from the culture medium. Additionally, the in vivo delivery of [ mice, suggesting that SR-BI might be involved in regulating plasma HDL levels in situations where lipid metabolism is perturbed, as is the case when PEMT is absent.
To gain further insight into the mechanism by which PEMT deficiency results in the induction of hepatic SR-BI, we analyzed mRNA levels by quantitative real-time PCR.
No difference in the amount of SR-BI mRNA transcripts was detected when liver samples from Pemt -/-mice were compared to samples from P e m t +/+ mice. There is evidence that hepatic SR-BI expression is not highly controlled at the transcriptional level (57), although hormonal regulation of its promoter has been reported (58, 59) . Thus, it is likely that hepatic SR-BI levels are mainly determined by protein turnover, cellular targeting and/or protein-protein interactions (57) . Any of these posttranslational regulatory mechanisms could potentially explain the increased protein expression and/or the enhanced lipid uptake observed in P e m t -/-hepatocytes. PDZK1, a PDZ domaincontaining protein, has been shown to interact with the C-terminal cytoplasmic domain of SR-BI (60, 61) . It has been proposed that PDZK1 serves as a scaffold for SR-BI to be targeted to the appropriate subcellular localization or to be in close proximity of downstream signaling molecules. PDZK1 might also regulate the rate of retro-endocytosis of SR-BI and/or help in selective lipid sorting after internalization of HDL particles.
Nonetheless, PDZK1 is believed to be an important regulator of hepatic SR-BI's stability, as demonstrated by a 95% reduction of SR-BI protein levels in mice lacking PDZK1 (61, 62) . Moreover, expression of PDZK1 in SR-BI expressing cells caused an up-regulation of SR-BI protein without affecting its mRNA levels (63) . We thus examined hepatic PDZK1 expression in the absence of PEMT and found greater levels of PDZK1 (1.5-fold) in knockout cells. Interestingly, this upregulation also correlates with the extent of the detected increase in hepatic SR-BI protein levels. Although the exact mechanism underlying the increased expression of PDZK1 and SR-BI is still unknown, it appears that a change in cellular PC homeostasis can significantly affect hepatic lipid uptake pathways.
A change in SR-BI protein turnover is also possible under conditions of altered hepatic PC biosynthesis. We aimed to analyze protein synthesis and degradation over time in primary hepatocytes obtained from Pemt Performing such an experiment wasdifficult in primary cultures sinceafter the isolation procedure, hepatocytes do not make significantly more SR-BI. Indeed, SR-BI protein levels decrease consistently over time, starting soon after plating the cells (data not shown). Thus, the experiment was not designed to determine protein degradation as there was no obvious decline of [ 35 S] -signal over a chase period of 8 h. Also, in a study on the intracellular localization of SR-BI, Ahras et al. localized the HDL receptor to late endosomal/lysosomal compartments. They reported that after an 8 h cycloheximide chase, SR-BI protein was still abundantly found in association with the lysosomal compartment (64) . Their data suggest that this intracellular pool of SR-BI is fairly stable and that SR-BI plays a role in endosomal/lysosomal lipid trafficking and does not undergo significant degradation (64) , in agreement with our observations (Fig. 7) . The potential existence of two different pools of SR-BI is quite interesting, especially since the internalization of HDL particles appears to be independent of this intracellular SR-BI pool, relying mostly on the cell surface expression of the receptor, i.e the plasma membrane pool (64) .
Thus, our results clearly show that even with unchanged mRNA expression, there is more SR-BI protein present in liver samples of PEMTdeficient mice. An increase in SR-BI protein levels with unchanged mRNA expression has previously been reported by Nakamura et al. (63) . Rats were treated with glucagon and the results showed increased hepatic SR-BI protein expression without any change in mRNA levels (63) .
A lack of correlation between protein expression and mRNA levels of SR-BI has also been reported in hepatocytes by Shetty et al. (65) . Interestingly, following isolation of hepatocytes, there appear to be slightly more SR-BI protein synthesis occurring in 2 h of incubation of Pemt (Fig. 7) .
As dimerization of SR-BI protein has been demonstrated (43, 66) , we analyzed the formation of SR-BI oligomeric complexes in mice lacking the PEMT pathway.
The results obtained from the Blue Native PAGE analysis revealed no difference in the size or the ratios of the complexes formed by SR-BI in the livers of Pemt
and Pemt -/-mice. In different cell lines, SR-BI has been shown to homodimerize and to form higher order oligomers (42, 43, 66) . The expression and dimerization of SR-BI on the cell surface appears to influence microvillar channel formation in steroidogenic tissues and correlates with a greater selective lipid uptake (67) . The effect of SR-BI self-association and/or of its oligomeric forms on the efficiency of HDL lipid uptake by the liver, however, has not been investigated. Our study demonstrates a 1.5-fold up-regulation of SR-BI protein, thus it is not surprising to detect proportionally more SR-BI in the monomeric form and as part of oligomer complexes. Also, we cannot exclude the possibility that the hepatic oligomers detected by Blue Native PAGE are hetero-oligomers of SR-BI with other proteins of similar molecular weight, such as the 70 kDa PDZK1 (68).
Since apoA-I remains in the plasma compartment and is available for re-lipidation, SR-BI appears to protect against atherosclerosis despite the fact that HDL cholesterol levels are lowered by over-expression of SR-B1 (69) (70) (71) (72) (73) (74) . In the absence of PEMT, the up-regulation of hepatic SR-BI (due to altered PC biosynthetic pathways in the liver) might alter plasma lipids without affecting the amount of plasma apoA-1. Interestingly, elimination of PEMT in mice lacking the low density lipoprotein receptor significantly reduced atherosclerotic lesions after the mice are fed a high fat/high cholesterol diet for 12 weeks 2 . The exact mechanism linking PC biosynthetic pathways to SR-BI is yet to be discovered. A few years ago, our laboratory showed that PEMT-derived PC is preferentially targeted to secretion into bile (9) . In the case of PEMT deficiency, it is possible that the liver compensates by up-regulating the uptake of HDL lipids in order to maintain efficient biliary secretion of PC. Thus, it is conceivable that PEMT-derived PC is involved in controlling plasma HDL metabolism. Consistent with the idea that PC homeostasis in the liver can regulate HDL levels, mice in which the l e v e l o f C T P : p h o s p h o c h o l i n e cytidylyltransferase α (CTα) in the liver has been reduced by 85% also exhibit decreased levels of circulating HDL lipids (75) . More studies on mice lacking either PEMT or the CDP-choline pathway should provide further insight into how hepatic PC biosynthesis is involved in the regulation of plasma lipoprotein levels. and Pemt -/-mice were homogenized in 1% dodecyl maltoside-containing lysis buffer and 50 µg were electrophoresed by 4-20% gradient gel under non-denaturating conditions. This immunoblot is representative of analyses from at least 6 mice for each genotype. 
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